MRK
Merck & Company Inc
147.20$
+1.5%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 39.7% | 37.8% | 35.2% | 32.2% | 31.9% | 30.7% | 32.8% | 28.0% | 29.4% | 26.8% | 23.7% | 28.0% | |
| 60.3% | 62.2% | 64.8% | 67.8% | 68.1% | 69.3% | 67.2% | 72.0% | 70.6% | 73.2% | 76.3% | 72.0% | |
| 17.0% | 17.0% | 25.8% | 25.8% | 23.1% | 24.9% | 32.3% | 25.1% | 22.9% | 50.8% | 28.0% | 19.3% | |
| 27.5% | 26.1% | 0.6% | 0.6% | 18.9% | 22.3% | 16.3% | 15.2% | 12.6% | 12.6% | 12.0% | 16.3% | |
| 44.5% | 43.1% | 50.9% | 50.9% | 46.9% | 49.0% | 53.8% | 44.9% | 39.8% | 68.3% | 44.8% | 35.8% | |
| 15.8% | 19.1% | 13.8% | 16.9% | 21.1% | 20.3% | 13.4% | 27.1% | 30.8% | 4.9% | 31.5% | 36.2% | |
| 1.7% | 1.7% | 1.7% | 1.9% | 1.8% | 2.3% | 2.0% | 1.7% | 1.6% | 1.9% | 2.0% | 2.1% | |
| 40.9% | 13.7% | 11.7% | 16.3% | 20.6% | 18.3% | 14.1% | 28.5% | 27.7% | 3.1% | 31.1% | 32.4% | |
| 12.7% | 2.4% | 1.8% | 10.2% | 5.9% | 4.0% | 3.2% | 3.1% | 3.2% | 2.5% | 4.4% | 4.3% | |
| 28.2% | 11.2% | 9.8% | 6.0% | 14.7% | 25.2% | 17.0% | 26.8% | 24.5% | 0.6% | 26.7% | 28.1% | |
| 58.5% | 31.5% | 27.2% | 29.8% | 33.1% | 29.1% | 24.5% | 36.8% | 36.0% | 11.5% | 40.1% | 43.5% |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.